"Measure what can be measured and make measurable what is not so"

Galileo Galilei

A medical technology company enabling precision and personalised medicine to become a reality in neuroscience research and development.

Our Missions

Accelerating and derisking drug development in neuroscience

We transform any smartphone into a digital measurement laboratory for precision medicine development

Empowering patients to be the centre of gravity of neurological disease research

Indivi and RC2NB

Pioneering the future of precision neurology

Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.

Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).

The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.

Indivi and RC2NB

Pioneering the future of precision neurology

Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.

Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).

The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.

Indivi and RC2NB

Pioneering the future of precision neurology

Indivi and RC2NB are dedicated to unlocking the immense potential of digital measurements in drug development.

Indivi’s close research cooperation with the teams at RC2NB (Co-CEOs Profs. Cristina Granziera and Ludwig Kappos) creates a unique intersection between expert knowledge in Software Development, Data Science, Clinical Science and Advanced Analytics (including Machine Learning and Artificial Intelligence).

The Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) is an internationally renowned institution embedded in Basel University Hospital and University of Basel.
RC2NB specialises in the development and integration of innovative tools that comprehensively characterise the disease process, thus facilitating the development of better treatments and enabling personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.

Your partner in advancing precision endpoints to accelerate and derisk drug development in neurology

Indivi MS (dreaMS)

Find out about how our Indivi MS (dreaMS) medical device app can help you

Indivi MS (dreaMS)

Find out about how our Indivi MS (dreaMS) medical device app can help you

Indivi MS (dreaMS)

Find out about how our Indivi MS (dreaMS) medical device app can help you

For professionals

How Indivi aims at setting the new gold standard in neurological disorder assessment

For professionals

How Indivi aims at setting the new gold standard in neurological disorder assessment

For professionals

How Indivi aims at setting the new gold standard in neurological disorder assessment

Our technologies

Advancing digital endpoints to accelerate and derisk drug development in neuroscience

Our technologies

Advancing digital endpoints to accelerate and derisk drug development in neuroscience

Our technologies

Advancing digital endpoints to accelerate and derisk drug development in neuroscience